Suchergebnis | Hamburg Open Science

Facetten

3 Einträge gefunden

Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphoma
2015 - Forschungsinformationssystem des UKE
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy.
2011 - Forschungsinformationssystem des UKE
Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma.
2007 - Forschungsinformationssystem des UKE